Overview
Rucsandra Dobrota practices in Zurich, Switzerland. Dobrota is rated as an Elite expert by MediFind in the treatment of Scleroderma. Their top areas of expertise are Systemic Sclerosis (SSc), Scleroderma, Acute Interstitial Pneumonia, and Interstitial Lung Disease.
Their clinical research consists of co-authoring 43 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 39 articles in the study of Scleroderma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- SclerodermaDobrota isElite. Learn about Scleroderma.
- Systemic Sclerosis (SSc)
- Advanced
- Acute Interstitial Pneumonia
- GangreneDobrota isAdvanced. Learn about Gangrene.
- Interstitial Lung DiseaseDobrota isAdvanced. Learn about Interstitial Lung Disease.
- Experienced
- ArthritisDobrota isExperienced. Learn about Arthritis.
- EsophagitisDobrota isExperienced. Learn about Esophagitis.
- Gastroesophageal Reflux Disease (GERD)
- HypertensionDobrota isExperienced. Learn about Hypertension.
- Localized SclerodermaDobrota isExperienced. Learn about Localized Scleroderma.
- Pulmonary FibrosisDobrota isExperienced. Learn about Pulmonary Fibrosis.